Gary Lubin, who founded the company and has served as CEO, will retire on March 1, 2025, and remain on the Board of Directors.
The vision and leadership of Mr. Lubin led to the development of a market leader in the clinical trial operations market.
It has been an honor to have founded and served as the CEO of Ledger Run, and I am excited for the future.
Mr. Chinnici has spent most of his career in the life sciences industry, first at IBM and then as an early leader at Veeva Systems.
John Durrett said that Gary's dedication to fostering a collaborative, creative culture and innovative application of technologies has been instrumental in Ledger Run's success.
The Ledger Run is transforming clinical trial business operations through an innovative suite of trial management solutions.
There is a source for the Ledger Run.
Do not sell or share my information.

Source prnewswire